Adirondack Trust Company’s VanEck Biotech ETF BBH Stock Holding History

Adirondack Trust Company’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-75	Closed	-$9K	–	351
2019 Q1	$9K	Hold	75	–	–	0.01%	255
2018 Q4	$8K	Hold	75	–	–	0.01%	253
2018 Q3	$10K	Hold	75	–	–	0.01%	253
2018 Q2	$9K	Hold	75	–	–	0.01%	254
2018 Q1	$9K	Hold	75	–	–	0.01%	255
2017 Q4	$9K	Hold	75	–	–	0.01%	246
2017 Q3	$10K	Hold	75	–	–	0.01%	234
2017 Q2	$9K	Sell	75 -225	-75%	-$27.1K	0.01%	243
2017 Q1	$36K	Hold	300	–	–	0.03%	179
2016 Q4	$32K	Buy	+300	New	+$32.6K	0.02%	184

Other funds holding BBH

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TIA

Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

BRM

Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return

Adirondack Trust Company's BBH Position: Q2 2019 in Review

Adirondack Trust Company sold out of VanEck Biotech ETF (BBH) in Q2 2019, closing a stake of 75 shares — an estimated $9K sold.

Adirondack Trust Company first reported a position in BBH in Q4 2016 and held it in 10 quarters. The position peaked at $36K in Q1 2017. 84 funds tracked by Wall St. Rank hold BBH as of Q2 2019.

Adirondack Trust Company reported no remaining VanEck Biotech ETF position as of Q2 2019 after selling out during the quarter.
Adirondack Trust Company sold 75 VanEck Biotech ETF shares in Q2 2019, an estimated $9K.
Adirondack Trust Company first reported a position in VanEck Biotech ETF in Q4 2016 and held it in 10 quarters.
Adirondack Trust Company's VanEck Biotech ETF position peaked at $36K in Q1 2017.
84 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2019.

Based on Adirondack Trust Company's 13F filing for Q2 2019, filed 15 Jul 2019.